Middle East Healthcare Co.’s (Saudi German Health) Q1 2023 net profit more than doubled to SAR 50.1 million, compared to SAR 20.5 million in the year before.
| Item | Q1 2022 | Q1 2023 | Change |
|---|---|---|---|
| Revenues | 513.32 | 637.99 | 24.3 % |
| Gross Income | 165.02 | 225.50 | 36.6 % |
| Operating Income | 35.28 | 76.51 | 116.9 % |
| Net Income | 20.49 | 50.12 | 144.6 % |
| Average Shares | 92.04 | 92.04 | - |
| EPS (Riyals) | 0.22 | 0.54 | 144.6 % |
| Item | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Revenues | 617.96 | 637.99 | 3.2 % |
| Gross Income | 204.01 | 225.50 | 10.5 % |
| Operating Income | 57.96 | 76.51 | 32.0 % |
| Net Income | 33.16 | 50.12 | 51.1 % |
| Average Shares | 92.04 | 92.04 | - |
| EPS (Riyals) | 0.36 | 0.54 | 51.1 % |
The year-on-year (YoY) profit jump was attributed to the increased patients count in Saudi German Health’s inpatient and outpatient departments. This is in addition to higher operational efficiency amid a rise in the occupancy rates of the group's new expansions.
Sequentially, Saudi German Health’s net profit climbed 51.1% from SAR 33.16 million in Q4 2022, driven by increased revenues and operational capacity that pushed the number of patients higher.
Shareholders’ equity, after minority interest, advanced to SAR 1.41 billion by the end of the three-month period, from SAR 1.36 billion a year ago.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}